ITCMDBv1
Clinical TrialID 7263

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery

NCT00814047

Blood Flow Velocity|Autoregulation|Ocular Physiology

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7263
Evidence Id
7263
Core Evidence Id
7263
Source Clinical Trial Id
7254
Herb2 Clinical Trial Id
HBCT007254
Nct Id
NCT00814047
Title
The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Blood Flow Velocity|Autoregulation|Ocular Physiology
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
Intervention
DRUG: Yohimbine hydrochloride
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
Male
Age
Adult
Enrollment
18
Outcome Measure
Relation between blood pressure and local perfusion parameters.
Sponsor Collaborator
Medical University of Vienna
Funded By
OTHER
Location
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, 1090, Austria
Other Id
OPHT-280604
Start Date
Primary Completion Date
Completion Date
First Posted
2008-12-23
Results First Posted
Last Update Posted
2008-12-23
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00814047
Title Cn
Title En
The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery
Bilingual Status
semi_complete